Roche
RO.SW
#43
Rank
S$438.55 B
Marketcap
S$551.22
Share price
0.70%
Change (1 day)
28.62%
Change (1 year)

Roche (RO.SW) - Cash on Hand

Cash on Hand as of December 2025 : S$25.28 Billion

According to Roche's latest financial reports the company has S$25.28 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Roche - Cash on Hand chart (from 2006 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31S$25.09 B-3.69%
2024-12-31S$26.06 B57.85%
2023-12-31S$16.50 B16.48%
2022-12-31S$14.17 B-26.49%
2021-12-31S$19.28 B4.17%
2020-12-31S$18.50 B12.15%
2019-12-31S$16.50 B-9.42%
2018-12-31S$18.21 B10.57%
2017-12-31S$16.47 B27.36%
2016-12-31S$12.93 B-1.46%
2015-12-31S$13.13 B-16.06%
2014-12-31S$15.64 B-8.22%
2013-12-31S$17.04 B-9.09%
2012-12-31S$18.74 B20.32%
2011-12-31S$15.58 B3.7%
2010-12-31S$15.02 B-40.33%
2009-12-31S$25.17 B-11.6%
2008-12-31S$28.48 B-7.42%
2007-12-31S$30.76 B0.32%
2006-12-31S$30.66 B16.04%
2005-12-31S$26.42 B42.13%
2004-12-31S$18.59 B-15.91%
2003-12-31S$22.11 B-35.61%
2002-12-31S$34.34 B-39.58%
2001-12-31S$56.83 B26.99%
2000-12-31S$44.75 B13.93%
1999-12-31S$39.28 B18.48%
1998-12-31S$33.15 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
S$28.52 B 12.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$9.02 B-64.31%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$16.91 B-33.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$9.43 B-62.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$15.57 B-38.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$8.30 B-67.17%๐Ÿ‡ซ๐Ÿ‡ท France
Becton Dickinson
BDX
S$1.05 B-95.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$7.37 B-70.83%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$5.89 B-76.67%๐Ÿ‡ฌ๐Ÿ‡ง UK